These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 3151339)

  • 1. Efficacy of pefloxacin in experimental Pseudomonas aeruginosa pyelonephritis.
    Ritzerfeld W
    Chemioterapia; 1987 Jun; 6(2 Suppl):184-5. PubMed ID: 3151339
    [No Abstract]   [Full Text] [Related]  

  • 2. [A clinical trial of pefloxacin (Abaktal) in the treatment of acute pyelonephritis].
    Gorski J; Wehnert J; Lange D; Koch H; Wichmann G
    Z Urol Nephrol; 1990 Feb; 83(2):55-60. PubMed ID: 2195800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An experimental model of Pseudomonas aeruginosa renal infection in rats.
    Hatala M; Prát V; Liska M; Konícková L; Slugen I
    Zentralbl Bakteriol Orig A; 1975; 230(4):466-9. PubMed ID: 807056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-vivo effectiveness of the antibiotic colistin in preventing growth of Pseudomonas aeruginosa.
    Furtado D; Gorrill RH
    J Pathol Bacteriol; 1968 Jul; 96(1):65-76. PubMed ID: 4970058
    [No Abstract]   [Full Text] [Related]  

  • 5. Carbenicillin (Pyopen) in treatment of severe systemic infections and pyelonephritis due to Pseudomonas aeruginosa and Proteus.
    Liwski R; Gietko G
    Pol Med J; 1970; 9(3):611-20. PubMed ID: 4989147
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparison between the effects of carbenicillin and new penicillin BRL-2288 on a model of B. pyocyaneus pyelonephritis in rats (author's transl)].
    Hatala M; Liska M; Morávek J; Konícková L; Prát V
    Cas Lek Cesk; 1974 Jun; 113(24):720-3. PubMed ID: 4217652
    [No Abstract]   [Full Text] [Related]  

  • 7. [Dioxidine in experimental pyocyanic pyelonephritis in rats].
    Rudzit EA; Lisitsa LI; Zinchenko TA
    Farmakol Toksikol; 1978; 41(2):199-202. PubMed ID: 658366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ceftazidime activity in experimental pseudomonas pyelonephritis in rats.
    Ritzerfeld W
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():257-9. PubMed ID: 19802995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ofloxacin: therapeutic activity in experimental infections.
    Guerra L; Erani E; Xerri L
    Chemioterapia; 1986 Dec; 5(6):375-8. PubMed ID: 3467874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experimental chemotherapy of pyelonephritis caused by Pseudomonas aeruginosa].
    Zinchenko TA; Rudzit EA; Lisitsa LI
    Antibiot Khimioter; 1988 Oct; 33(10):789-94. PubMed ID: 3063223
    [No Abstract]   [Full Text] [Related]  

  • 11. [Carbenicillin treatment of Pseudomonas aeruginosa infections and Proteus infections in infants].
    Korányi G; Pesti E
    Acta Paediatr Acad Sci Hung; 1972; 13(4):345-56. PubMed ID: 4198126
    [No Abstract]   [Full Text] [Related]  

  • 12. Esmolol: immunomodulator in pyelonephritis by Pseudomonas aeruginosa.
    Dimopoulos G; Theodorakopoulou M; Armaganidis A; Tzepi IM; Lignos M; Giamarellos-Bourboulis EJ; Tsaganos T
    J Surg Res; 2015 Sep; 198(1):175-84. PubMed ID: 26073350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the Therapeutic Efficacy of Zingerone Nanoparticles in Treating Biofilm-Associated Pyelonephritis Caused by Pseudomonas aeruginosa in the Murine Model.
    Sharma K; Bose SK; Chhibber S; Harjai K
    Inflammation; 2020 Dec; 43(6):2344-2356. PubMed ID: 32948964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental pyelonephritis. 18. Pseudomonas aeruginosa and E. coli prostatic infection in the rat and the effects of water diuresis.
    Freedman LR
    Yale J Biol Med; 1972 Dec; 45(6):559-71. PubMed ID: 4570550
    [No Abstract]   [Full Text] [Related]  

  • 15. [Use of a combination of dioxidine and gentamycin in Pseudomonas aeruginosa pyelonephritis in rats].
    Zinchenko TA
    Farmakol Toksikol; 1982; 45(4):64-7. PubMed ID: 7128790
    [No Abstract]   [Full Text] [Related]  

  • 16. Contribution of free radicals to Pseudomonas aeruginosa induced acute pyelonephritis.
    Mittal R; Sharma S; Chhibber S; Harjai K
    Microb Pathog; 2008; 45(5-6):323-30. PubMed ID: 18771720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential therapeutic role of histatin derivative P-113d in experimental rat models of Pseudomonas aeruginosa sepsis.
    Cirioni O; Giacometti A; Ghiselli R; Orlando F; Kamysz W; D'Amato G; Mocchegiani F; Lukasiak J; Silvestri C; Saba V; Scalise G
    J Infect Dis; 2004 Jul; 190(2):356-64. PubMed ID: 15216473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dioxidine and carbenicillin in Pseudomonas aeruginosa pyelonephritis in rats].
    Zinchenko TA; Starkov MV; Rudzit EA; Lisitsa LI
    Farmakol Toksikol; 1982; 45(1):65-70. PubMed ID: 7056384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical effect of Kasugamycin on urinary tract infections due to Pseudomonas aeruginosa].
    Maekawa A
    J Antibiot B; 1967 Jun; 20(3):197-8. PubMed ID: 4965586
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of experimental Pseudomonas aeruginosa infection with carbenicillin and antiserum. Dose-effect relations].
    Mai K; Eckhardt R
    Arzneimittelforschung; 1972 Apr; 22(4):809-13. PubMed ID: 4626081
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.